Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Bionor Pharma ApS
APS
In liquidation
CVR 36445564
Strandvejen 100, 2900
Hellerup
Forskning og eksperimentel udvikling indenfor bioteknologi
·
NACE 721100
Est. 2014 · 11 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Forskning og eksperimentel udvikling indenfor bioteknologi
/
Bionor Pharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
2M
5M
7M
9M
0M
2015
8M
2016
EBITDA
DKK millions
3M
2M
1M
1M
0M
1M
2015
2M
+100%
2016
Income statement
DKK thousands
Item
2015
2016
Gross profit
—
7.876
Staff expenses
-5.692
-5.845
EBITDA
1.033
2.032
Depreciation & amort.
-120
-1.092
EBIT
913
940
Net financials
-15
-4
Profit before tax
897
936
Tax
209
211
Net profit
688
725
Balance sheet
DKK thousands
Item
2015
2016
Total assets
6.189
4.790
Equity
3.677
4.402
Long-term debt
0
0
Short-term debt
2.474
388
Total debt
2.474
388
Financial ratios
5-year trend
EBITDA margin (of gross profit)
25.8%
This company
2015
2016
Equity ratio
91.9%
This company
38.2%
Market median
+141% vs market
2015
2016
Return on equity
16.5%
This company
18.4%
Market median
+10% vs market
2015
2016
Net profit margin (of gross profit)
9.2%
This company
2015
2016
Asset turnover (of gross profit)
1.64×
This company
2015
2016
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
2015
2016
Annual reports & filings
Annual report 2016
Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
View
PDF
Annual report 2015
Filed via CVR / Virk · Period 2014-11-15 – 2015-12-31
View
PDF
More on Bionor Pharma ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
